Robert A. Kyle
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments 437
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research 150
- Oncology top 0.02%
- Cancer Treatment and Pharmacology 82
- Peptidase Inhibition and Analysis 67
- Nephrology top 0.05%
- Parathyroid Disorders and Treatments 61
- Molecular Biology top 0.02%
- Amyloidosis: Diagnosis, Treatment, Outcomes 289
- Protein Degradation and Inhibitors 103
-
- Lymphoma Diagnosis and Treatment 59
- Co-authors
- S. Vincent RajkumarMorie A. GertzAngela DispenzieriPhilip R. GreippMartha Q. LacyJohn A. LustShaji KumarTerry M. Therneau
- Cited by
- HematologyGeneticsOncology
- Journals
- Mayo Clinic Proceedings (235 papers)Blood (156 papers)Journal of Clinical Oncology (54 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Robert A. Kyle
953 papers receiving 57.7k citations
Hit Papers
Peers
Comparison fields: 5 of 202
- Hematology 34.0k
- Genetics 12.5k
- Oncology 19.2k
- Nephrology 5.0k
- Molecular Biology 35.1k
Countries citing papers authored by Robert A. Kyle
This map shows the geographic impact of Robert A. Kyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Kyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Kyle more than expected).
Fields of papers citing papers by Robert A. Kyle
This network shows the impact of papers produced by Robert A. Kyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Kyle. The network helps show where Robert A. Kyle may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert A. Kyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus. | 2014 | 0 |
| 4 | 2013 | 120 | |
| 5 | 2011 | 29 | |
| 6 | 2010 | 80 | |
| 7 | 2010 | 121 | |
| 8 | 2009 | 87 | |
| 9 | Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studybreakdown → | 2009 | 743 |
| 10 | 2009 | 226 | |
| 11 | 2009 | 228 | |
| 12 | 2007 | 285 | |
| 13 | 2007 | 195 | |
| 14 | Leopold Ruzicka--1939 Nobel Prize in chemistry. | 2007 | 1 |
| 15 | 2006 | 26 | |
| 16 | 2006 | 1 | |
| 17 | 2001 | 0 | |
| 18 | 2000 | 3 | |
| 19 | 1998 | 4 | |
| 20 | 1975 | 99 |
About Robert A. Kyle
Robert A. Kyle is a scholar working on Hematology, Genetics and Nephrology, having authored 1.0k papers that have together received 59.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (437 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (289 papers), Chronic Lymphocytic Leukemia Research (150 papers), Protein Degradation and Inhibitors (103 papers), Cancer Treatment and Pharmacology (82 papers), Peptidase Inhibition and Analysis (67 papers), Parathyroid Disorders and Treatments (61 papers) and Lymphoma Diagnosis and Treatment (59 papers). The work is most often cited by research in Hematology (34.0k citations), Genetics (12.5k citations) and Oncology (19.2k citations). Robert A. Kyle has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include S. Vincent Rajkumar, Morie A. Gertz, Angela Dispenzieri, Philip R. Greipp, Martha Q. Lacy, John A. Lust, Shaji Kumar, Terry M. Therneau, Dirk R. Larson and Rafaël Fonseca. Their work appears in journals such as Mayo Clinic Proceedings, Blood, Journal of Clinical Oncology, American Journal of Hematology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.